5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)Advanced Solid TumorsRecruitingPhase 12026-10-07NCT05067283
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)Neoplasms by Site, Thoracic Neoplasms, autosomal dominant Parkinson disease 4, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32026-09-25NCT06170788
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)autosomal dominant Parkinson disease 4, cancer, neoplasmRecruitingPhase 22026-09-02NCT07252739
Effectiveness of Clear Aligner Systems in Mixed Dentition Maxillary Transverse DeficiencyMaxillary Transverse DeficiencyActive, not recruitingNot applicable2026-05-14NCT07586163
Far-Infrared Socks for Neuropathic Pain and Nerve Function in Diabetic PatientsDiabetes Complications, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, diabetes mellitus, endocrine system disorder, nervous system disorder, neuralgia, neuromuscular disease, perceptual disorders, peripheral nervous system disorderEnrolling by invitationNot applicable2025-03-19NCT06880484